News and commentary from the endocrinology world
"I didn't realize it would be such a heated discussion," says a mayor of one such town
No adverse events resulted in treatment discontinuation
Panelists acknowledge difficulty generating stronger data in ultra-rare disease
Agency appears unswayed by mitochondria-targeting drug for rare cardioskeletal disease
Association was more apparent when additionally adjusting for BMI
Octreotide subcutaneous depot also improved treatment satisfaction, quality of life